about
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboratio...
Read More
5.41
-0.05
(-0.92%)
1.0M
XNAS Volume
XNAS 15 Jul, 2025 5:30 PM (EDT)
Not Eligible
Affordable Valuation
Technically Moderately Bullish
CureVac N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..